Wu, Z., Hu, Y., Xu, M., Chen, Z., Yang, W., Jiang, Z., . . . Yin, W. (2021). Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: A randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infectious Diseases, 21(6), 803-813.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Wu, Zhiwei, et al. "Safety, Tolerability, and Immunogenicity of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Healthy Adults Aged 60 Years and Older: A Randomised, Double-blind, Placebo-controlled, Phase 1/2 Clinical Trial."
Lancet Infectious Diseases 21, no. 6 (2021): 803-813.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Wu, Zhiwei, et al. "Safety, Tolerability, and Immunogenicity of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Healthy Adults Aged 60 Years and Older: A Randomised, Double-blind, Placebo-controlled, Phase 1/2 Clinical Trial."
Lancet Infectious Diseases, vol. 21, no. 6, 2021, pp. 803-813.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.